We previously reported that cytosolic fractions of bovine brain contain two immunologically distinct forms of phospholipase C (PLC), PLC-I and PLC-if. We now report the purification of another form of inositolphospholipidspecific phospholipase C from bovine brain cytosol, designated PLC-HI, and the comparison of the catalytic properties of the three isozymes. Approximately 450 ,ug of pure PLC-HI was obtained from 36 bovine brains, and it had a rinal specific activity of 30-40 pmol of phosphatidylinositol hydrolyzed per min per mg of enzyme in the presence of 0.1% deoxycholate.
The hydrolysis of inositolphospholipids by phospholipase C is a major pathway of signal transduction during the response of many cells to stimulation by hormones, peptide growth factors, neurotransmitters, and other regulatory ligands (reviewed in refs. [1] [2] [3] [4] . The inositolphospholipid-specific phospholipase C (PLC) is present in most cell types and, as has been demonstrated by a number of workers, can be resolved into several active fractions in many crude tissue extracts (5, 6) and in partially purified preparations (7) (8) (9) . Multiple activity peaks might be derived from proteolytic cleavage or multiple oligomeric states of a PLC enzyme (10) . However, the presence of PLC isozymes was clearly demonstrated in sheep seminal vesicular glands and bovine brain.
Hofmann and Majerus (11) purified one enzyme of Mr 65,000 and partially purified another enzyme with a Mr of 85,000 from seminal vesicular glands; they showed that antibodies raised against the Mr 65,000 enzyme do not react with the other. Recently, two immunologically distinct PLC enzymes were purified to homogeneity in our laboratory (10) . The Mr of the first enzyme, designated PLC-I, was 150,000 under denaturing conditions, and the purified PLC-I existed mainly in a dimeric form and in a tetrameric form to a smaller extent. The second enzyme, designated PLC-Il, had a Mr of 145,000 and was present predominantly as a monomer and to a smaller extent as a dimer. Both polyclonal and monoclonal antibodies directed against either enzyme did not cross-react with the other (10, 12) . It is clear from the molecular weights of the purified enzymes and from the immunoblot experiment that the two forms of PLC identified from bovine brain are different from the two forms from seminal vesicles. In addition, studies with antibodies indicate that PLC-I is highly localized in brain, whereas PLC-Il is widely distributed in various tissues (P.-G.S., W. C. Choi, K.-Y.L., S.H.R., and S.G.R., unpublished results). Nevertheless, the reasons for the existence of multiple forms of PLC and for the tissuespecific distribution remain unclear.
When cytosolic fractions of bovine brain were eluted through an immunoaffinity gel to which antibodies specific to PLC-I and antibodies specific to PLC-Il were attached, 20-30o of the PLC activity consistently was not bound. This led us to look for another form of PLC in the bovine brain cytosolic fraction. Here, we report the purification of a third form of PLC, which is immunologically and catalytically distinct from the other two. The catalytic properties of the three enzymes are compared in this report.
MATERIALS AND METHODS Materials. Bovine serum albumin (A0281 or A7906) was purchased from Sigma, and the Mono S column was from Pharmacia. All other materials were as described (12) .
Phospholipase C Assay. During the purification of PLC, the phosphatidylinositol (Ptdlns) hydrolyzing activity was measured with Ptd[2-3H]Ins in the presence of0. 1% deoxycholate as described (10 (13) . All assays were run at 370C and terminated as described (11 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
brains, and proteins were precipitated at pH 5.0 as described (12) . The protein precipitates were dissolved in 1 liter of 20 mM Tris1HCl, pH 7.4/5 mM EGTA/2 mM phenylmethylsulfonyl fluoride/0.1 mM dithiothreitol/0.5 mM diisopropyl fluorophosphate. The turbid solution was centrifuged at 150,000 x g for 45 min.
Step 2: Ion-exchange chromatography on DE-52 DEAEcellulose. The supernatant from step 1 was applied on a DE-52 DEAE-cellulose column (8 x 40 cm), which had been equilibrated with 20 mM Tris-HCl, pH 7.6/1 mM EGTA/0.1 mM dithiothreitol. The column was eluted with a 6-liter linear KCl gradient from 0 to 225 mM KCl in 50 mM Tris-HCl, pH 7.6/1 mM EGTA/0.1 mM dithiothreitol. Three PLC activity peaks were eluted. The peak fractions were pooled separately as indicated in Fig. 1 . The first peak, which contained PLC-III, was further purified immediately in the next step, whereas the second and third peaks were stored frozen for purification of PLC-I and PLC-II, respectively, by the method described earlier (12) .
Step 3: Heparin-agarose chromatography. The PLC-III fractions pooled from the previous step (750 ml) were directly applied to a heparin-agarose column (5 x 15 cm) equilibrated with 20 mM Hepes, pH 7.0/0.1 mM dithiothreitol/1 mM EGTA. The column was eluted with a 1.8-liter linear gradient ofNaCl from 100 to 700 mM NaCl in equilibration buffer. The peak fractions (240 ml) were pooled as indicated in Fig. 2A , concentrated to -10 ml in an Amicon filtration apparatus, and stored frozen to be combined with concentrated fractions of PLC-III from two other identical preparations.
Step 4: Reverse-phase chromatography on TSK phenyl-5-PW. Solid KCI was added to the concentrated fractions (35 ml) from step 3 to give a final concentration of 3 M, and the mixtures were centrifuged to remove denatured proteins. The supernatants were applied at a flow rate of 5.0 ml/min to a HPLC preparative TSK phenyl-5-PW column (21.5 x 150 mm; Bio-Rad) equilibrated with 20 mM Hepes, pH 7.0/3 M KCI/1 mM EGTA/0.1 mM dithiothreitol. Elution was continued at 5.0 ml/min with a decreasing KCl gradient from 3 M to 1.2 M KCI for 10 min and with a decreasing KCl gradient from 1.2 M to 0 M KCl for 20 min. Fractions (25 ml) containing PLC activity were pooled and washed in an Amicon filtration apparatus with 20 mM 2-(N-morpholino)-ethanesulfonic acid, pH 5.7/0.1 mM dithiothreitol/1 mM EGTA and finally concentrated to =10 ml.
Step 5: Ion-exchange chromatography on a Mono S column. The washed protein solution (-10 ml) from step 4 was applied at a flow rate of 1.0 ml/min to a Mono S column (7 x 6 mm) equilibrated with 20 mM 2-(N-morpholino)ethanesulfonic acid, pH 5.7/0.1 mM dithiothreitol/1 mM EGTA. Elution was continued at 1.0 ml/min with an NaCl gradient from 0 to 300 mM NaCl for 20 min and from 300 mM to 1 M for 10 min. Peak fractions (1.2 ml) were collected manually, diluted with 2 ml of 20 mM Hepes (pH 7.0), concentrated in a Centricon microconcentrator (Amicon) to %-0.5 ml, separated into aliquots, and stored at -20°C.
Enzyme Concentration. The concentrations of PLC-I, -II, and -III were estimated using an average protein absorptivity of Ai10 = 1.14.
Other Methods. PAGE and immunoblotting with rabbit antiserum or murine monoclonal antibodies were as described (12) . The preparation and properties of the monoclonal antibodies will be described elsewhere.
RESULTS
Purification of PLC-Ill. Chromatography of the 150,000 x g supernatants of bovine brain cytosolic fractions on a DEAE-cellulose column yielded three PLC activity peaks, PLC-Ill, PLC-I, and PLC-Il, which eluted sequentially as shown in Fig. 1 . In the previous paper reporting the purifi- cation of PLC-I and PLC-Il (12) , cytosolic fractions were centrifuged at 13,000 x g. The resulting turbid supernatants were adsorbed on a thin bed of DEAE-cellulose on a sintered glass funnel, and the bed was washed with a low ionic strength buffer to remove turbid lipid material before the washed DEAE-cellulose was poured onto a column already containing a layer of DEAE-cellulose. The column was then eluted with a KCI gradient. This procedure yielded only two activity peaks: the first peak was PLC-I and the second was PLC-Il. This was probably because PLC-III was washed off during the batch-type DEAE chromatography procedure as evidenced by a low level of PLC activity detected in the unbound flow-through fractions. In the current procedure, after ultracentrifugation the supernatants were directly applied to a DEAE column equilibrated with a low ionic strength buffer. Consequently, PLC-Ill was retained and was eluted as shown in Fig. 1 .
Next, three purification steps-chromatography on heparin-agarose gel ( Fig. 2A) , an HPLC phenyl column (Fig. 2B) , and cation-exchange resin Mono S (Fig. 2C )-allowed us to obtain 450 ,ug of homogeneous PLC-III from 36 bovine brains. The purified PLC-III had a final specific activity of 30-40 ,umol of PtdIns cleaved per min per mg of enzyme in the presence of 0.1% deoxycholate. A summary of the purification is presented in Table 1 . In addition, we also purified PLC-I and PLC-II from the corresponding peak fractions of the DEAE column.
Polyacrylamide Gel Analysis and Immunoblot. Fig. 3 shows the results of the analysis of the three purified PLC enzymes on a NaDodSO4/polyacrylamide gradient gel and the immunoblots of the same gel. The Mr of the newly purified PLC-Ill is 85,000 (Fig. 3A, lane 3) , as compared to 150,000 for PLC-I (Fig. 3A, lane 1) and 145,000 for PLC-II (Fig. 3A , lane 2). Immunoblots were carried out using a mixture of three murine monoclonal antibodies that recognize different epitopes of PLC-I (Fig. 3B) . Similarly, a mixture of six different monoclonal anti-PLC-II antibodies were employed in Fig.  3C . As already reported, PLC-II was not recognized by anti-PLC-I antibodies, and PLC-I was not recognized by anti-PLC-II antibodies (12) . Furthermore, PLC-III could not be detected by either of the two hybridoma proteins, indicating that PLC-Ill is another immunologically independent enzyme. Rabbit antibodies raised against either PLC-I or PLC-II also did not react with PLC-III (data not shown). The results of analysis of the three purified enzymes on nondenaturing polyacrylamide gradient gels are shown in Fig. 4 . As reported previously (10) , undamaged PLC-I exists mainly in a dimeric form and in a tetrameric form to a smaller extent, whereas PLC-II is predominantly monomeric and, to a smaller extent, dimeric. Two broad bands were observed for PLC-III. The estimated Mr values are 150,000-170,000 for the intense band and -250,000 for the faint band in lane 3 of pH Dependence. The effect of pH on the Ptd[3H]Ins hydrolyzing activity measured by using unilamellar vesicles of pure PtdIns in the presence of 1 mM free Ca2l is shown in Fig. 5 . All three enzymes exhibited pH optima at an acidic pH, =4.8 for PLC-I, 5.0 for PLC-Il, and 5.5 for PLC-Ill. As the pH was increased, PLC-I activity decreased rapidly, and PLC-Il activity decreased less rapidly, whereas PLC-III activity decreased by only 30% and remained constant between pH 7.0 and 8.5. The specific activities of the three enzymes were similar at their optimal pH. However, the order of specific activity was PLC-Ill > PLC-Il > PLC-I at neutral pH. Fig. 6 . With unilamellar vesicles of PtdIns as substrate, the hydrolysis rates of PLC-I and PLC-Ill increased with increasing Ca2+ concentration up to 10 mM, whereas the activity of PLC-I increased slowly until it reached a maximum at 6 mM Ca2' and then decreased. Although the PtdIns hydrolyzing specific activities of the three enzymes were similarly low below 10 ,uM Ca2+, the difference became significant at higher concentrations ofCa2+. For example, the specific activities observed with PLC-I, -II, and -III were 2, 8, and 24 ,umol-min-l-mg-1, respectively, at 10 mM Ca2 .
With PtdInsP2 vesicles as substrate, the rates for the three enzymes increased with increasing Ca2+ concentration until they reached maxima at 10-100 ttM. Ca2+ at concentrations higher than 100 .uM inhibited the activities, perhaps owing to precipitation of the substrate. At all Ca2+ concentrations, the specific activities were in the order PLC-I > PLC-Ill > PLC-II. At 0.1-1 1LM Ca2+, the PtdInsP2 hydrolyzing activities of PLC-I and PLC-III were much higher than their PtdIns hydrolyzing activities. For example, at 1 gM Ca2+, the PtdInsP2 hydrolysis rates were 5.0 and 2.8 umol-mind'mgfor PLC-I and PLC-Ill, respectively, while the PtdIns hydrolysis rate was 0.3 Amol min -mg-1 for both enzymes The PtdIns hydrolyzing activities of PLC-I, -II, and -III were separated by DEAE chromatography, and the relative contribution of each enzyme to the total amount of activity in the homogenate and in the pH 5.0 precipitate was estimated from the area of each activity in Fig. 1 . to an oligomer of PLC-Ill because the PLC-III preparation exhibited no visible impurity bands when analyzed by NaDodSO4/PAGE. Arrows indicate Mr standards from top to bottom: thyroglobulin (669,000), ferritin (440,000), catalase (232,000), lactate dehydrogenase (140,000), and BSA (67,000). Native polyacrylamide gel analysis of PLC-I and PLC-II has been described previously (10) .
Effect ofBSA on PLC Activities. The Ca2+-dependent activity profiles shown in Fig. 7 for the Ptdlns hydrolysis by PLC-I and PLC-II are similar to those reported previously (12) . However, the profiles for PtdInsP2 hydrolysis were significantly different from the previous profiles in which PLC-I activities were much lower than those shown in Fig. 6 . We found that this discrepancy resulted because BSA had been included at 0.15 mg/ml in the assay mixture, whereas it was absent in the current experiment. In the previous experiments, the enzymes had been diluted in a BSA solution. Therefore, the effect of BSA on the PLC activities was studied.
As shown in Fig. 7 , the most prominent changes in response to BSA were observed in the PtdInsP2 hydrolysis by PLC-I. Fifty percent inhibition occurred at 50 ,ug/ml (IC50 = 50 ,ug/ml). The PtdIns hydrolysis by PLC-I was also inhibited but at higher BSA concentration (IC50 450 tug/ml). Both the Ptdlns and PtdInsP2 hydrolyzing activities of PLC-II were not significantly affected by BSA, whereas those of PLC-III exhibited biphasic responses: the activities were enhanced by BSA at lower concentration and then decreased slowly with further additions. These BSA effects were probably not due *1t I 4)E '. (30,000 cpm) was the substrate. The symbols for PLC-I, -II, and -III were also the same as in A. Free Ca2' concentrations were calculated as described (12) . Arrows ( T ) indicate where no CaCl2 was added.
to small size contaminants such as metal ions and lipid molecules in BSA because similar results were obtained either with BSA (Sigma A7906) dialyzed against a buffer containing EGTA or with fatty acid free BSA (Sigma A0281).
DISCUSSION
Our current results clearly demonstrate that bovine brain contains at least three immunologically distinct PLC enzymes. The use of purified enzymes allowed us to compare their catalytic properties directly under identical experimental conditions. Similarly to PLC-I and PLC-II, PLC-11 was specific to inositolphospholipids and did not utilize phosphatidylcholine and phosphatidylethanolamine as substrate (data not shown). When vesicles derived from pure Ptdlns were used as substrate, the three enzymes exhibited similar specific activities at their optimum pHs, which are all acidic but differ from one another. However, at neutral pH, Ptdlns hydrolyzing activities were significantly different: PLC-Ill was the most active and PLC-I was the least active. This order of activity, PLC-Ill > PLC-II > PLC-I, could be observed at 0.5-10 mM Ca2". Their PtdIns hydrolyzing activities were low below 0.5 mM Ca2' and nearly zero at 0.1 MM Ca2+. The catalytic properties toward PtdInsP2 were very different from those toward PtdIns. All three enzymes exhibited significantly higher specific activities toward PtdInsP2 at 0.1-10 AM Ca2+. Furthermore, the order of activity was different. At all Ca2+ concentrations, PLC-I and PLC-Ill were more active than PLC-Il. Consequently, the ratios of PtdIns hydrolysis to PtdInsP2 hydrolysis catalyzed by each enzyme were very different. PLC-I, which had been shown to exist in plasma membrane as well as in cytosol (14) , showed the highest specificity for PtdInsP2. (13, 18) . Unlike this lipid effect, however, the BSA effect must be on the enzyme rather than on the substrate, because the three enzymes were affected differently. Purified (19, 20 (10) .
Therefore, we can count at least five distinct PLC enzymes in mammalian tissues: (i) Mr 150,000 PLC-I, which seems to be specifically localized in brain cells, (ii) Mr 145,000 PLC-Il, which is widely distributed in various tissues, (iii) Mr 85,000 PLC-III, which might be the same as the enzyme identified in seminal vesicles, (iv) Mr 65,000 enzyme purified from seminal vesicles, liver, and platelets, and (v) Mr 140,000 platelet enzyme, which could not be recognized by either anti-PLC-I antibodies or anti-PLC-Il antibodies.
